FDA 21 CFR Part 11 — Electronic Records; Electronic Signatures
US federal regulation establishing criteria for acceptance of electronic records and electronic signatures by the FDA. 30 requirements across electronic records (validation, audit trails, system access controls, authority checks, device checks, education and training, documentation, open and closed system controls), electronic signatures (uniqueness, identity verification, signature manifestations, signature/record linking), and biometric and non-biometric authentication controls. Applies to all FDA-regulated industries including pharmaceuticals, medical devices, biologics, and food.
Controls: 92
Total Mappings: 155
Publisher: U.S. Food and Drug Administration (FDA) Version: 1997 (updated guidance 2003) AC (12) AT (4) AU (13) CA (3) CM (8) CP (3) IA (11) IR (1) MP (1) PE (2) PL (3) PM (3) PS (5) RA (4) SA (7) SC (8) SI (4)
AC Access Control
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| AC-01 | Policy and Procedures | §11.10(d) |
| AC-02 | Account Management | §11.10(d)§11.10(g)§11.100(a)§11.200(a)(2)§11.300(a)§11.300(b)§11.300(c) |
| AC-03 | Access Enforcement | §11.10(d)§11.10(g) |
| AC-05 | Separation of Duties | §11.10(d)§11.10(g) |
| AC-06 | Least Privilege | §11.10(d)§11.10(g) |
| AC-07 | Unsuccessful Logon Attempts | §11.10(d)§11.200(a)(1)(ii) |
| AC-11 | Device Lock | §11.10(d)§11.200(a)(1)(i)§11.200(a)(1)(ii) |
| AC-12 | Session Termination | §11.10(d)§11.200(a)(1)(i) |
| AC-16 | Security and Privacy Attributes | §11.10(g) |
| AC-17 | Remote Access | §11.30§11.300(d) |
| AC-19 | Access Control for Mobile Devices | §11.10(h) |
| AC-24 | Access Control Decisions | §11.10(g) |
AT Awareness and Training
AU Audit and Accountability
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| AU-01 | Policy and Procedures | §11.10(e) |
| AU-02 | Event Logging | §11.10(e)§11.50 |
| AU-03 | Content of Audit Records | §11.10(e)§11.50 |
| AU-04 | Audit Log Storage Capacity | §11.10(e) |
| AU-05 | Response to Audit Logging Process Failures | §11.10(e) |
| AU-06 | Audit Record Review, Analysis, and Reporting | §11.10(e) |
| AU-07 | Audit Record Reduction and Report Generation | §11.10(e) |
| AU-08 | Time Stamps | §11.10(e) |
| AU-09 | Protection of Audit Information | §11.10(b)§11.10(e) |
| AU-10 | Non-repudiation | §11.10(e)§11.30§11.50§11.70 |
| AU-11 | Audit Record Retention | §11.10(b)§11.10(c)§11.10(e) |
| AU-12 | Audit Record Generation | §11.10(e)§11.50 |
| AU-14 | Session Audit | §11.10(e) |
CA Security Assessment and Authorization
CM Configuration Management
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| CM-02 | Baseline Configuration | §11.10(f) |
| CM-03 | Configuration Change Control | §11.10(k) |
| CM-04 | Impact Analyses | §11.10(a) |
| CM-05 | Access Restrictions for Change | §11.10(k) |
| CM-06 | Configuration Settings | §11.10(f) |
| CM-07 | Least Functionality | §11.10(f) |
| CM-08 | System Component Inventory | §11.10(h) |
| CM-09 | Configuration Management Plan | §11.10(k) |
CP Contingency Planning
IA Identification and Authentication
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| IA-01 | Policy and Procedures | §11.10(d) |
| IA-02 | Identification and Authentication (Organizational Users) | §11.10(d)§11.100(a)§11.200(a)(1)§11.200(a)(1)(ii)§11.200(a)(2)§11.200(a)(3) |
| IA-03 | Device Identification and Authentication | §11.10(h) |
| IA-04 | Identifier Management | §11.10(d)§11.100(a)§11.100(b)§11.200(a)(2)§11.300(a)§11.300(c) |
| IA-05 | Authenticator Management | §11.10(d)§11.100(a)§11.100(b)§11.200(a)(1)§11.200(a)(1)(ii)§11.200(a)(2)§11.300(a)§11.300(b)§11.300(c)§11.300(e) |
| IA-06 | Authentication Feedback | §11.200(a)(1)§11.300(d) |
| IA-07 | Cryptographic Module Authentication | §11.200(a)(1) |
| IA-08 | Identification and Authentication (Non-organizational Users) | §11.100(a) |
| IA-09 | Service Identification and Authentication | §11.10(h) |
| IA-11 | Re-authentication | §11.200(a)(1)(i)§11.200(a)(1)(ii) |
| IA-12 | Identity Proofing | §11.100(b)§11.200(a)(3) |
IR Incident Response
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| IR-06 | Incident Reporting | §11.300(c) |
MP Media Protection
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| MP-04 | Media Storage | §11.10(c) |
PE Physical and Environmental Protection
PL Planning
PM Program Management
PS Personnel Security
RA Risk Assessment
SA System and Services Acquisition
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| SA-03 | System Development Life Cycle | §11.10(a) |
| SA-05 | System Documentation | §11.10(k) |
| SA-08 | Security and Privacy Engineering Principles | §11.10(a) |
| SA-10 | Developer Configuration Management | §11.10(a) |
| SA-11 | Developer Testing and Evaluation | §11.10(a)§11.10(f) |
| SA-15 | Development Process, Standards, and Tools | §11.10(a) |
| SA-17 | Developer Security and Privacy Architecture and Design | §11.10(a) |
SC System and Communications Protection
| Control | Name | FDA 21 CFR Part 11 References |
|---|---|---|
| SC-07 | Boundary Protection | §11.30 |
| SC-08 | Transmission Confidentiality and Integrity | §11.30§11.70§11.300(d) |
| SC-10 | Network Disconnect | §11.200(a)(1)(i) |
| SC-12 | Cryptographic Key Establishment and Management | §11.30 |
| SC-13 | Cryptographic Protection | §11.30§11.300(d) |
| SC-17 | Public Key Infrastructure Certificates | §11.30 |
| SC-23 | Session Authenticity | §11.30§11.300(d) |
| SC-28 | Protection of Information at Rest | §11.10(b)§11.10(c)§11.70 |